rss
08-12-2016, 08:34 PM
AngioSculptX, a New Drug-Coated PTCA Catheter **w Available in Europe
http://www.medgadget.com/wp-content/uploads/2016/08/AngioSculptX.jpg
Spectranetics out of Colorado Springs, Colorado won the CE Mark in Europe to bring to market its*AngioSculptX Drug-coated PTCA (percutaneous transluminal coronary angioplasty) Scoring Balloon Catheter. Originally developed by AngioScore, a company purchased by Spectranetics, the device is a drug coated version of the company’s proven AngioSculpt PTCA scoring balloon catheter and is indicated for treatment of*coronary artery ste**sis,*which includes*in-stent reste**sis.
“AngiosculptX represents a unique coronary scoring tech**logy that incorporates a drug coating. Given its clinical results, it is a significant advancement in therapy options for patients,” said Professor Bru** Scheller of Saarlandes University Clinic in Homburg, Germany, in a statement.
Via:*Spectranetics… (https://globenewswire.com/news-release/2016/08/10/863212/0/en/Spectranetics-Receives-CE-Mark-for-AngioSculptX.html)
This post AngioSculptX, a New Drug-Coated PTCA Catheter **w Available in Europe (http://www.medgadget.com/2016/08/angiosculptx-new-drug-coated-ptca-catheter-**w-available-europe.html) appeared first on Medgadget (http://www.medgadget.com).
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=OK_JuZcCZB4:NcPxmm_1l-8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=OK_JuZcCZB4:NcPxmm_1l-8:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=OK_JuZcCZB4:NcPxmm_1l-8:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=OK_JuZcCZB4:NcPxmm_1l-8:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/OK_JuZcCZB4
http://www.medgadget.com/wp-content/uploads/2016/08/AngioSculptX.jpg
Spectranetics out of Colorado Springs, Colorado won the CE Mark in Europe to bring to market its*AngioSculptX Drug-coated PTCA (percutaneous transluminal coronary angioplasty) Scoring Balloon Catheter. Originally developed by AngioScore, a company purchased by Spectranetics, the device is a drug coated version of the company’s proven AngioSculpt PTCA scoring balloon catheter and is indicated for treatment of*coronary artery ste**sis,*which includes*in-stent reste**sis.
“AngiosculptX represents a unique coronary scoring tech**logy that incorporates a drug coating. Given its clinical results, it is a significant advancement in therapy options for patients,” said Professor Bru** Scheller of Saarlandes University Clinic in Homburg, Germany, in a statement.
Via:*Spectranetics… (https://globenewswire.com/news-release/2016/08/10/863212/0/en/Spectranetics-Receives-CE-Mark-for-AngioSculptX.html)
This post AngioSculptX, a New Drug-Coated PTCA Catheter **w Available in Europe (http://www.medgadget.com/2016/08/angiosculptx-new-drug-coated-ptca-catheter-**w-available-europe.html) appeared first on Medgadget (http://www.medgadget.com).
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=OK_JuZcCZB4:NcPxmm_1l-8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=OK_JuZcCZB4:NcPxmm_1l-8:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=OK_JuZcCZB4:NcPxmm_1l-8:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=OK_JuZcCZB4:NcPxmm_1l-8:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/OK_JuZcCZB4